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Introduction: The aim of this study was to evaluate the usefulness of the APACHE II (Acute Physiology and Chronic
Health Evaluation II), SAPS II (Simplified Acute Physiology Score II) and SOFA (Sequential Organ Failure Assessment)
scores compared to simpler models based on age and Glasgow Coma Scale (GCS) in predicting long-term outcome
of patients with moderate-to-severe traumatic brain injury (TBI) treated in the intensive care unit (ICU).
Methods: A national ICU database was screened for eligible TBI patients (age over 15 years, GCS 3–13) admitted in
2003–2012. Logistic regression was used for customization of APACHE II, SAPS II and SOFA score-based models for
six-month mortality prediction. These models were compared to an adjusted SOFA-based model (including age)
and a reference model (age and GCS). Internal validation was performed by a randomized split-sample technique.
Prognostic performance was determined by assessing discrimination, calibration and precision.
Results: In total, 1,625 patients were included. The overall six-month mortality was 33%. The APACHE II and SAPS
II-based models showed good discrimination (area under the curve (AUC) 0.79, 95% confidence interval (CI) 0.75 to
0.82; and 0.80, 95% CI 0.77 to 0.83, respectively), calibration (P > 0.05) and precision (Brier score 0.166 to 0.167). The
SOFA-based model showed poor discrimination (AUC 0.68, 95% CI 0.64 to 0.72) and precision (Brier score 0.201) but
good calibration (P > 0.05). The AUC of the SOFA-based model was significantly improved after the insertion of
age and GCS (ΔAUC +0.11, P < 0.001). The performance of the reference model was comparable to the APACHE
II and SAPS II in terms of discrimination (AUC 0.77; compared to APACHE II, ΔAUC −0.02, P = 0.425; compared to
SAPS II, ΔAUC −0.03, P = 0.218), calibration (P > 0.05) and precision (Brier score 0.181).
Conclusions: A simple prognostic model, based only on age and GCS, displayed a fairly good prognostic performance
in predicting six-month mortality of ICU-treated patients with TBI. The use of the more complex scoring systems
APACHE II, SAPS II and SOFA added little to the prognostic performance.Introduction
Comparing mortality rates of patients treated in different
ICUs is meaningless if differences in baseline factors
affecting outcome, particularly severity of illness or injury,
are not taken into account. Therefore, scoring systems
that enable quantification of severity of illness are para-
mount for the evaluation of quality of intensive care [1-4].
Moreover, precise data on severity of illness and the* Correspondence: rahul.br.raj@icloud.com
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reproduction in any medium, provided the oraccompanying risk of death are essential in clinical studies
[5,6]. However, a scoring system and its associated risk
prediction model is useful only if it demonstrates both
good calibration and discrimination [7-10].
Among the most commonly used severity of illness
scoring systems in intensive care are the APACHE II
(acute physiology and chronic health evaluation II)
and the SAPS II (simplified acute physiology score II)
[11-13]. They were developed for the general ICU
population and include equations for the prediction of
the risk of in-hospital death [11,12]. Another commonly
used scoring system is the SOFA (sequential organ failureThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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organ dysfunction, but has also been used for outcome
prediction [14-18].
Patients with traumatic brain injury (TBI) represent a
specific type of ICU patients with a substantially different
prognosis to the general ICU population [19]. Importantly,
in patients with TBI, hospital discharge mortality is a
poor outcome measure as it significantly underestimates
mortality rates [20]. Thus, using hospital mortality as an
endpoint may cause bias if discharge practices differ and
models able to adequately predict long-term outcomes
are needed [21-23]. The role of the ICU scoring systems
for long-term outcome prediction in patients with TBI
treated in the ICU is uncertain, and although TBI-specific
prognostic models are likely to be more accurate than the
ICU scoring systems in this patient group, they are not as
widely implemented [13,19]. Therefore, we decided to
evaluate the usefulness of the APACHE II, SAPS II and
SOFA scores in predicting six-month mortality after TBI
and to find out whether these scoring systems are of any
additional value compared to a simple model based only
on age and the GCS.
Methods
Using the database of the Finnish Intensive Care Consor-
tium (FICC) we retrieved data on patients who were
aged >15 years, and were treated in an ICU with neuro-
surgical expertise (university hospitals in Finland) during a
ten-year period (2003 to 2012). To exclude outcome bias
we only included patients with a moderate-to-severe TBI
(GCS ≤13) during the first ICU day [24]. The FICC is a
high-quality database that prospectively collects data
on the characteristics and severity of illness as well as
outcomes from ICUs all over Finland [25]. Treatment
standards in included institutions are according to the
Brain Trauma Foundation guidelines [26]. The Ethics com-
mittee of the Northern Savonia hospital district approved
the study. As the FICC database is an anonymous database
the Ethics committee of Northern Savonia hospital district
waived the need for informed consent. Following that, the
FICC board granted us access to the database.
Statistical analysis
We used the χ2 test (two-tailed) for categorical univariate
analyses. We tested continuous variables for skewness
and chose appropriate statistical tests accordingly. We
used the Mann-Whitney U-test for non-parametric data
and the Student t-test for parametric data. Parametric
data are presented as mean (SD) and non-parametric data
as median (IQR). The primary outcome was six-month
mortality; a secondary outcome was in-hospital mortality.
To assess the performance of the different scoring
systems a split-sample technique was used, where the study
population was randomly divided into a development andvalidation cohort [27]. Logistic regression analysis was
used for customization of the APACHE II, SAPS II and
SOFA-based prediction models for six-month mortality
prediction. The risk of death is calculated using the
equation:
1= 1þ e‐logit ;
where each scoring system has a defined logit (see
Additional file 1). For the adjusted SOFA, age was
added into the model as an additional variable and the
GCS component from the SOFA score was extracted
and inserted as a separate variable. A reference model,
including only age and the worst measured GCS in the
first 24 hours in the ICU, was built for comparison.
For the adjusted SOFA and reference models the age
and GCS were tested as binominal, categorical and
continuous variables. Dichotomization of GCS (based
on the median) and ten-year interval age-categorization
was found to yield the best results. All models were also
customized for in-hospital mortality prediction, in order
to assess differences in prognostic performances of each
scoring system regarding both short and long-term
mortality.
Scoring system performance was assessed by determining
discrimination, calibration and precision [28]. Discrimin-
ation refers to the ability to separate between those who
die and those who survive. It is measured by calculating
the area under the receiver operating characteristic curve
(AUC). An AUC of 0.50 is no better than mere chance,
whereas values > 0.90, >0.80 and >0.70 are considered
excellent, good and satisfactory, respectively [10]. The
AUC curves were compared to one another using the
non-parametric DeLong-DeLong test [29].
Calibration refers to the agreement between predicted
and observed mortality across different classes of risk and
is usually assessed using the Hosmer-Lemeshow Ĉ-test
(H-L) [10]. The H-L is similar to the χ2 test. The test
divides the patients according to the predicted risk of
death into equally sized deciles and compares the expected
number of deaths to the observed number of deaths in
each decile to generate a χ2 with an associated P-value;
the smaller the χ2, the bigger the P-value and the better
the goodness of fit, that is, calibration. A P-value >0.05
indicates no significant difference between the predicted
and observed outcome and the model is considered well-
calibrated [5,10]. However, the H-L test has been criticized
for being largely dependent on sample size and thus
non-informative in large datasets, and for dividing the
patients into deciles, not accounting for the individual
patient [7,9]. Furthermore, the classic calibration curves
often drawn based on the H-L test are not really curves
and should not be used as such (ten dots, which are
Figure 1 Study population. FICC, Finnish Intensive Care Consortium;
GCS, Glasgow coma scale.
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a line) [30].
To overcome the limitations of the H-L, we combined
the classic H-L test with a new statistical test for calibration,
the GiViTI calibration belt [30,31]. In addition to giving a
calibration curve that illustrates the relationship between
predicted risk and observed outcome over different levels
of risk, this technique also gives the confidence belt of the
curve, that is, an estimation of the degree of uncertainty
regarding the true location of the curve. In the GiViTI
calibration belt, the relationship between the predicted
and observed outcome is calculated by fitting a polynomial
logistic function between the logit transformation of the
predicted probability and outcome. The calibration belt
calculates the 80% CI (light gray area) and 95% CI (dark
gray area) surrounding the calibration curve. A statistically
significant deviation from the bisector vector (diagonal
line for perfect calibration) occurs when the 95% CI does
not cover the bisector.
Precision was measured by the Brier score, which is
the mean squared difference between the observed and
predicted outcome, comprehending both calibration and
discrimination [32]. When the incidence of the outcome
is 50% the Brier score ranges from 0.0 (perfect) to 0.25
(worthless) [33].
For the statistical analyses, IBM SPSS Statistics 20.0 for
Windows and R version 3.0.1 for Windows (R Foundation
for Statistical Computing, Vienna, Austria) were used. The
H-L calibration was plotted using the PredictABEL library
and the calibration belt was plotted using the GiViTI
calibration belt library [30,34,35].
Results
Baseline characteristics
In total 1,625 patients were included: 844 patients were
randomized to the development cohort and 781 to the
validation cohort (Figure 1). The median age was 55 years
(IQR 38 to 66). Overall crude 6-month mortality was 33%
(n = 540/1625); 64% of all deaths (n = 346) took place in
the index hospital. There were no significant differences
in baseline characteristics, severity scores or outcome
between the development and validation cohorts. Dif-
ferences in scoring system variables between 6-month
survivors and non-survivors are shown in Table 1 and in
Additional file 2. For the adjusted SOFA and the reference
models, the GCS was dichotomized to 3 to 6 and 7 to 13
(based on the median GCS). The relationship and effect of
GCS and age on 6-month mortality is shown in Table 2,
and illustrated in Additional file 3.
Hospital mortality performance
Following customization and validation the SAPS II showed
the highest discriminative power (AUC 0.81), followed
by the APACHE II (AUC 0.80), the adjusted SOFA (AUC0.79), the reference model (AUC 0.74) and the SOFA
(AUC 0.73). The AUCs of the SAPS II and APACHE II
were significantly higher compared to the reference
model (ΔAUC 0.07, P = 0.011; ΔAUC 0.06, P = 0.013,
respectively). The adjusted SOFA score showed signifi-
cantly improved discriminative power compared to the
original SOFA score (AUC 0.79 versus 0.73, ΔAUC
0.06, P = 0.018).
All models displayed good calibration for hospital mortal-
ity prediction with no significant over- or under-prediction
intervals, as measured by the GiViTI calibration belt (see
Additional files 4 and 5). Precision, as measured by the
Brier score, varied between 0.128 and 0.151.
Six-month mortality performance
The scoring systems showed a lower discriminative power
for predicting 6-month mortality compared to predicting
in-hospital mortality. Following customization and valid-
ation, the discriminative power was highest for SAPS II
(AUC 0.80), followed by APACHE II (AUC 0.79), the
adjusted SOFA (AUC 0.79), the reference model (AUC
0.77) and the SOFA (AUC 0.68) (Figure 2). The AUC of
the SOFA-based model was significantly improved after
the insertion of age and GCS (ΔAUC 0.11, P <0.001) to
match the ones of APACHE II (P = 0.920) and SAPS II
(P = 0.745). None of the scoring systems had higher
AUCs compared to the reference model (reference model
versus APACHE II, P = 0.425; reference model versus
SAPS II, P = 0.218) (Table 3).
All models showed good calibration for 6-month mor-
tality prediction according to the H-L test and none of
them displayed any significant deviations from the bisector
line by the GiViTI tests (P >0.05) (Figure 3). Precision, as
measured by the Brier score, ranged from 0.166 for SAPS II
to 0.201 for SOFA.












Age, years 55 (38 to 66) 56 (39–66) 54 (36–66) 0.288 52 (33–63) 61 (49–80) <0.001
GCS
3 to 6 828 (51) 420 (50) 408 (52) 0.318 419 (39) 409 (76) <0.001
7 to 13 797 (49) 424 (50) 373 (48) 666 (61) 131 (24)
APACHE II 22 (17 to 27) 22 (17 to 22) 22 (17 to 26) 0.784 19 (15 to 23) 27 (22 to 31) <0.001
SAPS II 43 (31 to 55) 43 (32 to 55) 44 (31 to 55) 0.988 38 (28 to 48) 56 (45 to 63) <0.001
SOFA 7 (5 to 10) 7 (5 to 10) 7 (5 to 10) 0.744 7 (5 to 9) 9 (7 to 11) <0.001
Length of stay, days
ICU 2 (1 to 5) 2 (1 to 5) 2 (1 to 5) 0.989 3 (1 to 6) 2 (1 to 4) <0.001
Hospital 6 (3 to 12) 6 (3 to 12) 6 (3 to 13) 0.457 7 (4 to 15) 4 (1 to 8) <0.001
Mortality
ICU 212 (13) 107 (13) 105 (13) 0.647 NA 212 (39) NA
Hospital 346 (21) 173 (21) 173 (22) 0.416 NA 346 (64) NA
Six-month 540 (33) 278 (33) 262 (34) 0.795 NA 540 (100) NA
Categorical variables are presented as number (%), all continuous variables were highly skewed and are presented as median (IQR). APACHE II, acute physiology
and chronic health evaluation II; SAPS II, simplified acute physiology score II; SOFA, sequential organ failure assessment; NA, not applicable.
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Key findings
We conducted a retrospective study using a nationwide
multi-center ICU database, investigating the usefulness
of the APACHE II, SAPS II and SOFA scoring systems
in predicting long-term mortality for ICU-treated patients
with moderate-to-severe TBI. We found that after custom-
ization, both the APACHE II and SAPS II-based models
showed good performance (discrimination, calibration
and precision), whereas the SOFA-based model showed
poor performance (poor discrimination and precision but
good calibration) for predicting 6-month mortality. The
performance of the SOFA-based model was improved
with the inclusion of age and the GCS. However, none
of these severity score-based models showed superior
performance to a simple reference model including only
age and the GCS.Table 2 Relationship between age and Glasgow coma
scale (GCS) on six-month mortality
Age, years Mortality, % (absolute numbers)
All patients
(n = 1625)
GCS 7 to 13
(n = 797)
GCS 3 to 6
(n = 828)
<40 20 (86/438) 2 (4/210) 36 (82/228)
40 to 49 27 (50/187) 11 (11/97) 43 (39/90)
50 to 59 32 (116/363) 10 (17/167) 51 (99/196)
60 to 69 42 (129/309) 24 (36/149) 58 (93/160)
70 to 79 45 (104/232) 31 (39/125) 61 (65/107)
≥80 57 (55/96) 49 (24/49) 66 (31/47)
Age groups shown in rows and GCS groups in columns.Comparison with previous studies
Previous studies have suggested that APACHE II and
SAPS II are either poor or good predictors of short-term
mortality in trauma and TBI patients [36-39]. Reports on
long-term outcome prediction are scarce. Brinkman et al.
studied the APACHE IV and found that a customized
model had an AUC of 0.84 for predicting 6-month mortal-
ity in a non-selected ICU population [23]. In patients with
acute myocardial infarction, Huang et al. showed the SOFA
score to be of moderate value in predicting long-term
outcome in patients with acute myocardial infarction
(AUC 0.78) [40]. In comparison, the best-performing
scoring system in the present study (SAPS II) had an
AUC of 0.80.
Similar to the results of Brinkman et al., we found the
AUCs of the APACHE II- and SAPS II-based models to
be higher for predicting in-hospital compared to 6-month
mortality [23]. For in-hospital mortality prediction, the
SAPS II-based model was significantly superior compared
to the reference model. As shown in Additional file 2,
initial physiological derangements for patients discharged
alive from the hospital were uncommon, whereas they
were common for those dying in the hospital. However,
among those patients who were discharged alive from the
index hospital, there were more evident differences in
age and GCS between those who died in the following
6 months and those who survived. Accordingly, the AUC
of the reference model was found to be higher for 6-month
mortality compared to in-hospital mortality prediction.
These findings suggest that abnormal physiology captured
by severity of illness scores is of significance for in-hospital
but less so for long-term mortality prediction, as long-term
Figure 2 Area under the curve (AUC) for six-month mortality prediction. Left panel, the development cohort; right panel, the validation cohort.
APACHE II, acute physiology and chronic health evaluation II; GCS, Glasgow coma scale; SAPS II, simplified acute physiology score II; SOFA, sequential organ
failure assessment.
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and the GCS.
Compared to the APACHE II and SAPS II, the SOFA
score seems to be of limited value in predicting long-
term mortality in critically ill TBI patients. One obvious
reason for this is that the SOFA score does not pay






APACHE II 0.81 0.78, 0.84
SAPS II 0.81 0.77, 0.84
SOFA 0.68 0.64, 0.72
Adjusted SOFA* 0.78 0.75, 0.81
Reference† 0.75 0.72, 0.78
Validation cohort
APACHE II 0.79 0.75, 0.82
SAPS II 0.80 0.77, 0.83
SOFA 0.68 0.64, 0.72
Adjusted SOFA* 0.79 0.76, 0.82
Reference† 0.77 0.74, 0.80
*Adjusted SOFA with the addition of age and GCS (as a separate variable); †referen
analysis and thus only calculated for the validation cohort. Calibration P-values >0.0
evaluation II; SAPS II, simplified acute physiology score II; SOFA, sequential organ fa
GiViTI, Italian Group for the Evaluation of Intervention in Intensive Care Medicine; Npatient group [41]. Furthermore, multiple organ failure
(MOF), well demonstrated by a high SOFA score, is a
rare complication of TBI, occurring in less than 1% of
all TBI patients treated in the ICU [42,43]. In the
present study, only one out of 1,625 patients had a
SOFA liver score of 4 and 23 patients had a SOFA renal
score of 4. Including age and GCS as a separate variableCalibration Precision











ce model including age and GCS; ‡the GiViTI is a calibration tool for external
5 indicate good calibration. APACHE II, acute physiology and chronic health
ilure assessment; AUC, area under the curve; H-L, Hosmer-Lemeshow Ĉ-test;
A, not applicable.
Figure 3 (See legend on next page.)
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Figure 3 Calibration for six-month mortality prediction in the validation cohort. The Italian Group for the Evaluation of Intervention in
Intensive Care Medicine (GiViTI) calibration belt (right) and the Hosmer-Lemeshow Ĉ-test (H-L) calibration plot (left), with a loess-smoother curve
connecting the 10 risk groups. The GiViTI belt visualizes risk intervals of under- and over-prediction, respectively, for a given model as the 95% CI
does not cross the red diagonal bisector line.
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so that the prognostic performance of the model matched
that of the best performing models (SAPS II- and APACHE
II-based models). This further strengthens the importance
of age and GCS in long-term outcome-prediction in this
patient group.
To assess calibration we used a new method, namely
the GiViTI calibration belt [30]. The GiViTI belt has
two main applications: performance comparison between
different centers and external validation of prediction
models [30,35,44]. Although the mathematical basis of
the GiViTI calibration belt has been shown elsewhere it
should be compared to the H-L test, which has been
considered the gold standard of calibration testing [31,35].
We found the GiViTI and H-L tests to generate similar
results for calibration. The main benefit of the GiViTI
test is to pinpoint intervals of under- and over-prediction
for a given model. Although no significant deviations from
the bisector line were noted for any of the models, the
reference and the adjusted SOFA models displayed a
less-than-perfect calibration belt for 6-month mortality
prediction. This is due to the higher degree of polynomial
function fitted between the predicted and observed out-
come, resulting in wide confidence intervals [35]. This
is to our knowledge one of the first clinical studies com-
paring the traditional H-L calibration test with the GiViTI
calibration belt [31]. The GiViTI calibration belt should
be strongly considered in further studies in addition to the
traditional H-L test.
Future implications
Future studies should compare the performance of general
ICU scoring systems to that of TBI-specific prediction
models, such as the IMPACT or the CRASH models
[45,46]. In the present study, the best performing scoring
system-based models showed AUCs between 0.79 and
0.80 (APACHE II, SAPS II) for predicting 6-month
mortality, whereas external validation studies of the
IMPACT model have shown AUCs up to 0.87 [47-49].
The general ICU scores lack data on several variables
that are important for outcome prediction in TBI
patients, for example, pupillary light reaction and head
computerized tomography (CT) scan characteristics and
signs of increased intracranial pressure, which may reduce
predictive ability [45,50,51].
In the era of a more widespread use of TBI-specific
prognostic models it is unlikely that future prospective
TBI studies will rely only on general ICU scoring systemsfor case-mix adjustment. However there are numerous
high-quality databases in the field of intensive care
and trauma medicine around the world that lack some
key variables limiting the use of TBI-specific prediction
models (for example, the IMPACT). Conversely, general
ICU scores (especially APACHE II and SAPS II) are ubi-
quitously collected in ICUs around the world and based
on our results, reliable case-mix adjustment for long-term
outcome prediction can be achieved by applying these
[13]. On the other hand in epidemiological studies on TBI
a simple model including only age and GCS also provides
sufficient accuracy. This has implications for case-mix
adjustment in forthcoming epidemiological studies [19].
Limitations
We acknowledge some limitations to our study. First, due
to the retrospective nature of the study we were limited to
using 6-month mortality as the primary outcome measure.
Although mortality is a more clear-cut end point, future
studies should consider outcome variables such as neuro-
logical outcome and quality of life. Second, as the FICC
database does not include radiological data or TBI-specific
baseline characteristics, we had to rely on physiological
data when evaluating injury severity and could not
study the performance of any of the available TBI-specific
prediction models, something of key importance for future
studies. Third, some long-term outcome data were missing,
limiting the power of the study.
Conclusion
A simple prognostic model, based only on age and GCS,
displayed a fairly good prognostic performance in pre-
dicting 6-month mortality of ICU-treated patients with
TBI. The use of the more complex scoring systems APA-
CHE II, SAPS II and SOFA added little to the prognostic
performance.
Key messages
 The APACHE II and SAPS II-based prediction models
showed equally good prognostic performance in
predicting 6-month mortality of ICU-treated patients
with TBI.
 The SOFA-based model displayed poor performance
in 6-month mortality prediction. However, after the
inclusion of age and the GCS, as separate variables,
the performance improved significantly to match
that of the APACHE II and SAPS II.
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GCS, also displayed fairly good prognostic
performance in 6-month mortality prediction.
 Forthcoming epidemiological studies lacking
necessary data for the use of TBI-specific models
may use the general ICU scoring systems APACHE
II and SAPS II or the novel reference model for
adequate case-mix adjustment.
Additional files
Additional file 1: Scoring system equations for the calculation of
6-month mortality risk.
Additional file 2: Table showing scoring system characteristics
differences between 6-month survivors and non-survivors.
Additional file 3: Figure showing relationship and effect of age and
Glasgow coma scale on outcome. For the reference and adjusted
SOFA models, the GCS was dichotomized to 3 to 6 and 7 to 13, and age
was categorized by 10-year intervals (as shown). The figure demonstrates
a strong relationship and effect of age and GCS on 6-month mortality.
Additional file 4: Figure showing calibration for in-hospital mortality
prediction in the validation cohort. Right, Italian Group for the
Evaluation of Intervention in Intensive Care Medicine (GiViTI) calibration
belt; left, traditional Hosmer-Lemeshow Ĉ-test (H-L) calibration plot.
Additional file 5: Table showing scoring system performance for
in-hospital mortality.
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